The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Hologic to Participate in Four Investor Conferences

Thursday, July 14, 2011

Hologic to Participate in Four Investor Conferences10:00 EDT Thursday, July 14, 2011BEDFORD, Mass., July 14, 2011 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that company management will participate in the following conferences:Deborah Gordon, Vice President, Investor Relations, will host investor meetings at the Lazard Capital Markets Corporate Access Day in Chicago, Illinois on Tuesday, August 9, 2011. Management will not be presenting at this conference.Glenn Muir, Executive Vice President and Chief Financial Officer, will present at the 2011 Canaccord Genuity Growth Conference in Boston, Massachusetts on Wednesday, August 10, 2011 at 4:00 p.m. (Eastern). Glenn Muir will present at the Stifel Nicolaus Annual Healthcare Conference in Boston, Massachusetts on Wednesday, September 7, 2011 at 10:55 a.m. (Eastern). Rob Cascella, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference in New York City, New York on Tuesday, September 13, 2011 at 3:55 p.m. (Eastern). Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at www.hologic.com/investors-overview. Archives of the presentations will be available for replay following the conferences.About Hologic, Inc.Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast Magnetic Resonance Imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.Contact:Deborah GordonVice President, Investor RelationsHologic, Inc.(781) 999-7716SOURCE Hologic, Inc.